Inhibition of hexokinase-2 with targeted liposomal 3-bromopyruvate in an ovarian tumor spheroid model of aerobic glycolysis

References

• American Cancer SocietyCancer Facts and Figures 2014 Available from: http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2014/Accessed May 29, 2015
   Google Scholar
• GuarneriVPiacentiniFBarbieriEContePFAchievements and unmet needs in the management of advanced ovarian cancerGynecol Oncol2010117215215820056266
   PubMed Web of Science ®Google Scholar
• GilliesRJRobeyIGatenbyRACauses and consequences of increased glucose metabolism of cancersJ Nucl Med200849Suppl 224S42S18523064
   PubMedGoogle Scholar
• PelicanoHMartinDSXuRHHuangPGlycolysis inhibition for anticancer treatmentOncogene200625344633464616892078
   PubMed Web of Science ®Google Scholar
• FennemaERivronNRouwkemaJvan BlitterswijkCde BoerJSpheroid culture as a tool for creating 3D complex tissuesTrends Biotechnol201331210811523336996
   PubMed Web of Science ®Google Scholar
• ChangTTHughes-FulfordMMonolayer and spheroid culture of human liver hepatocellular carcinoma cell line cells demonstrate distinct global gene expression patterns and functional phenotypesTissue Eng Part A200915355956718724832
   PubMed Web of Science ®Google Scholar
• KnuchelRHofstadterFJenkinsWEMastersJRSensitivities of monolayers and spheroids of the human bladder cancer cell line MGH-U1 to the drugs used for intravesical chemotherapyCancer Res1989496139714012493980
   PubMed Web of Science ®Google Scholar
• HaycockJW3D cell culture: a review of current approaches and techniquesMethods Mol Biol201169511521042962
   PubMedGoogle Scholar
• FriedrichJSeidelCEbnerRKunz-SchughartLASpheroid-based drug screen: considerations and practical approachNat Protoc20094330932419214182
   PubMed Web of Science ®Google Scholar
• Mueller-KlieserWFreyerJPSutherlandRMInfluence of glucose and oxygen supply conditions on the oxygenation of multicellular spheroidsBr J Cancer19865333453533964538
   PubMed Web of Science ®Google Scholar
• KoYHVerhoevenHALeeMJCorbinDJVoglTJPedersenPLA translational study “case report” on the small molecule “energy blocker” 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedsideJ Bioenerg Biomembr201244116317022328020
   PubMed Web of Science ®Google Scholar
• Pereira da SilvaAPEl-BachaTKyawNInhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvateBiochem J2009417371772618945211
   PubMedGoogle Scholar
• KoYHSmithBLWangYAdvanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATPBiochem Biophys Res Commun2004324126927515465013
   PubMed Web of Science ®Google Scholar
• KoYHPedersenPLGeschwindJFGlucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinaseCancer Lett20011731839111578813
   PubMed Web of Science ®Google Scholar
• MathupalaSPRempelAPedersenPLGlucose catabolism in cancer cells identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditionsJ Biol Chem200127646434074341211557773
   PubMed Web of Science ®Google Scholar
• PatraKCWangQBhaskarPTHexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancerCancer Cell201324221322823911236
   PubMed Web of Science ®Google Scholar
• ShoshanMC3-Bromopyruvate: targets and outcomesJ Bioenerg Biomembr201244171522298255
   PubMed Web of Science ®Google Scholar
• BanghamADLiposomes: the Babraham connectionChem Phys Lipids1993641–32752858242839
   PubMed Web of Science ®Google Scholar
• AlexisFPridgenEMLangerRFarokhzadOCNanoparticle technologies for cancer therapySchäfer-KortingMDrug DeliveryHeidelberg, GermanySpringer2010
   Google Scholar
• GantaSDevalapallyHShahiwalaAAmijiMA review of stimuli-responsive nanocarriers for drug and gene deliveryJ Control Release2008126318720418261822
   PubMed Web of Science ®Google Scholar
• XuXKhanMABurgessDJA quality by design (QbD) case study on liposomes containing hydrophilic API: II. Screening of critical variables, and establishment of design space at laboratory scaleInt J Pharm2012423254355322155413
   PubMed Web of Science ®Google Scholar
• MagadalaPAmijiMEpidermal growth factor receptor-targeted gelatin-based engineered nanocarriers for DNA delivery and transfection in human pancreatic cancer cellsAAPS J200810456557619034673
   PubMed Web of Science ®Google Scholar
• MendelsohnJBaselgaJEpidermal growth factor receptor targeting in cancerSemin Oncol200633436938516890793
   PubMed Web of Science ®Google Scholar
• LiZZhaoRWuXIdentification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeuticsFASEB J200519141978198516319141
   PubMed Web of Science ®Google Scholar
• GatenbyRAGilliesRJWhy do cancers have high aerobic glycolysis?Nat Rev Cancer200441189189915516961
   PubMed Web of Science ®Google Scholar
• IshikawaKTakenagaKAkimotoMROS-generating mitochondrial DNA mutations can regulate tumor cell metastasisScience2008320587666166418388260
   PubMed Web of Science ®Google Scholar
• WardJPKingJRMathematical modelling of drug transport in tumour multicell spheroids and monolayer culturesMath Biosci2003181217720712445761
   PubMed Web of Science ®Google Scholar
• WenningLAMurphyRMCoupled cellular trafficking and diffusional limitations in delivery of immunotoxins to multicell tumor spheroidsBiotechnol Bioeng199962556257510099565
   PubMed Web of Science ®Google Scholar
• KostarelosKEmfietzoglouDPapakostasAYangWHBallangrudAMSgourosGEngineering lipid vesicles of enhanced intratumoral transport capabilities: correlating liposome characteristics with penetration into human prostate tumor spheroidsJ Liposome Res2005151–2152716194925
   PubMed Web of Science ®Google Scholar
• KostarelosKEmfietzoglouDPapakostasAYangWHBallangrudASgourosGBinding and interstitial penetration of liposomes within avascular tumor spheroidsInt J Cancer2004112471372115382056
   PubMed Web of Science ®Google Scholar